G-coupled protein receptors and breast cancer progression: Potential drug targets

Mini-Reviews in Medicinal Chemistry

Volumn 7, Issue 3, 2007, Pages 245-251

  Taborga, Marcelo ^a   Corcoran, Kelly E ^a   Fernandes, Neil ^a   Ramkissoon, Shakti H ^a   Rameshwar, Pranela ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b The State University of New Jersey   (United States)

Author keywords

Cancer; Chemokines; CXCR 4; Hematopoiesis; Metastasis; Tachykinins

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); AMD 3465; ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR 4; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; NEUROKININ; NEUROKININ 1; NEUROKININ 2; SAREDUTANT; STROMAL CELL DERIVED FACTOR 1; TACHYKININ; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; BONE MARROW METASTASIS; BREAST CANCER; CANCER GROWTH; CANCER REGRESSION; CANCER SCREENING; CANCER STEM CELL; CAUSE OF DEATH; DESENSITIZATION; DRUG TARGETING; HUMAN; LIPID RAFT; LONG TERM CARE; LOW DRUG DOSE; METASTASIS POTENTIAL; PROGNOSIS; PROTEIN TARGETING; REVIEW;

ANIMALS; BREAST NEOPLASMS; CHEMOKINES, CXC; DISEASE PROGRESSION; FEMALE; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, CXCR4; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, TACHYKININ;

EID: 33947655781     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955707780059826     Document Type: Review

References (61)

1. Jemal, A.; Siegel, R.; Ward, E.; Murray, T; Xu, J.; Smigal, C; Thun, M.J. CA Cancer J. Clin., 2006, 56, 106.
2. Yoneda, T.; Hiraga, T. Biochem. Biophys. Res. Commun., 2005, 328, 679.
3. Dontu, G.; Abdallah, W.M.; Foley, J.M.; Jackson, K.W.; Clarke, M.F.; Kawamura, M.J.; Wicha, M.S. Genes Dev., 2006, 17, 1253.
4. Kaushansky K. N. Engl. J. Med., 2006, 354, 2034.
5. Ramkissoon, S.H.; Patel, H.J.; Taborga, M.; Rameshwar, P. Expert Opin. Biol. Ther., 2006, 6, 109.
6. Moharita, A.; Harrison, J.S.; Rameshwar, P. Drug Des. Rev. Online, 2004, 1, 297.
7. Bigioni, M.; Benzzo, A.; Irrissuto, C.; Maggi, C.A.; Goso, C. Anti-cancer Drugs, 2005, 16, 1083.
8. Li, S.; Huang, S.; Peng, S.B. Int. J. Oncol., 2005, 27, 1329.
9. Tyndall, J.D.; Sandilya, R. Med. Chem., 2005, 1, 405.
10. Patel, P.H.; Ramkissoon, S.H.; Patel, P.S.; Rameshwar, P. Proc. Natl. Acad. Sci. USA, 2005, 102, 17436.
11. Burger, J.A.; Kipps, T.J. Blood, 2006, 107, 1761.
12. Muller, A.; Homey, B.; Soto, H.; Ge, N.; Catron, D.; Buchanan, M.E.; McClanahan, T.; Murphy, E.; Yuan, W.; Wagner, S.N.; Barrera, J.L.; Mohar, A.; Verastegui, E.; Zlotnik, A. Nature, 2001, 410, 50.
13. Wess, J. FASEB J., 1997, 5, 346.
14. Claps, C.M.; Corcoran, K.E.; Cho, K.J.; Rameshwar, P. Curr. Neurovasc. Res., 2005, 2, 319.
15. Juarez, J.; Bendall, L.; Bradstock, K. Curr. Pharm. Des., 2004, 10, 1245.
16. Charnaux, N.; Brule, S.; Hamon, M.; Chaigneau, T.; Saffar, L.; Prost, C.; Lievre, N.; Gattegno, L. FEBS J., 2005, 272, 1937.
17. Ganju, R.K.; Brubaker, S.A.; Meyer, J.; Dutt, P.; Yang, Y.; Qin, S.; Newman, W.; Groopman, J.E. J. Biol. Chem., 1998, 273, 23169.
18. Sotsois, Y.; Whittaker, G.C.; Westwick, J.; Ward, S.G. J. Immunol, 1999, 163, 5954.
19. Gazitt, Y. J. Hematother. Stem Cell Res., 2001, 10, 229.
20. Moharita A, Taborga M, Corcoran K, Bryan M, Patel P, Rameshwar P. Blood, 2006, 108, 3245.
21. Hermitte, F.; Brunet de la Grange, P.; Belloc, F.; Praloran, V.; Ivanovic, Z. Stem Cells, 2006, 24, 65.
22. Kucia, M.; Reca, R.; Miekus, K.; Wanzeck, J.; Wojakowski, W.; Janowska-Wieczorek, A.; Ratajczak, J.; Ratajczak, M.Z. Stem Cells, 2005, 23, 879.
23. Sadir, R.; Imberty, A.; Baleux, F.; Lortat-Jacob, H. J. Biol. Chem., 2004, 279, 43854.
24. Larochelle, A.; Krouse, A.; Metzger, M.; Orlic, D.; Donahue, R.E.; Fricker, S.; Bridger, G.; Dunbar, C.E.; Hematti, P. Blood, 2006, 107, 3772.
25. Rosenkilde, M.M.; Gerlach, L.; Jakobsen, J.S.; Skerlj, R.T.; Bridger, G.J.; Schwartz, T.W. J. Biol. Chem., 2004, 279, 3033.
26. De Clercq, E. Mini Rev. Med. Chem., 2005, 5, 805.
27. De Clercq, E. Nat. Rev., 2003, 2, 581.
28. Ficker, S.P.; Anastassov, V.; Cox, J.; Darkes, M.C.; Grujic, O.; Idzan, S.R.; Labrecque, J.; Lau, G.; Mosi, R.M.; Nelson, K.L.; Qin, L.; Santucci, Z.; Wong, R.S.Y. Biochem. Pharmacol., 2006, 72, 588.
29. Hatse, S.; Princen, K.; De Clercq, E.; Rosenkilde, M.M.; Schwartz, T.W.; Hernandez-Abad, P.E.; Skerlj, R.T.; Bridger, G.J.; Schols, D. Biochem. Pharmacol., 2005, 70, 752.
30. Barbaro, G.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C.T. Curr. Pharm. Des., 2005, 11, 1805.
31. Almeida, T.A.; Rojo, J.; Nieto, P.M.; Pinto, F.M.; Hernandez, M.; Martin, J.D.; Candenas, M.L. Curr. Med. Chem., 2004, 11, 2045.
32. Khawaja, A.M.; Rogers, D.F. Int. J. Biochem. Cell Biol., 1996, 28, 721.
33. O'Connor, T.M.; O'Connell, J.; O'Brien, D.I.; Goode, T.; Bredin, C.P.; Shanahan, F. J. Cell Physiol., 2004, 201, 167.
34. Pennefather, J.N.; Lecci, A.; Luz Cadenas, M.; Patak, E.; Pinto, F.M.; Maggi, C.A. Life Sci., 2004, 74, 1445.
35. Regoli, D.; Drapeau, G.; Dion, S.; D'Orleans-Juste, P. Pharmacology, 1989, 38, 1.
36. Quartara, L.; Maggi, C.A. Neuropeptides, 1998, 32, 1.
37. Figini, M.; Emanueli, C.; Grady, E.F.; Kirkwood, K.; Payan, D.G.; Ansel, J.; Gerard, C.; Geppetti, P.; Bunnett, N. Am. J. Physiol., 1997, 272, G785.
38. Holzer, P.; Holzer-Petsche, U. Pharmacol. Ther., 1997, 73, 219.
39. Inoue, H.; Nagata, N.; Koshihara, Y. Inflamm. Res., 1996, 45, 316.
40. Bowden, J.J.; Garland, A.M.; Baluk, P.; Lefevre, P.; Grady, E.F.; Vigna, S.R.; Bunnett, N.W.; McDonald, D.M. Proc. Natl. Acad. Sci. USA, 1994, 91, 8964.
41. Kramer M.S. Update on Substance P (NK-1 receptor) antagonists in clinical trials for depression. Neuropeptides, 2000, 34, 255.
42. Roila, F.; Fatigoni, S. Ann. Oncol., 2006, 17(Suppl. 2), ii96.
43. Johansson, A. Curr. Topics Med. Chem., 2003, 3, 1436.
44. MacKenzie, A.R.; Marchington, A.P.; Middleton, D.S.; Newman, S.D.; Jones, B.C. J. Med. Chem., 2002, 45, 5365.
45. Johanson, A. Curr. Top. Med. Chem., 2003, 3, 1436.
46. Lieb, K.; Fiebich, B.L.; Berger, M.; Bauer, J.; Schulze-Osthoff, K. J. Immunol., 1997, 159, 4952.
47. Fong, T. M.; Anderson, S. A.; Yu, H.; Huang, R. R.; Strader, C. D. Mol. Pharmacol, 1992, 41, 24.
48. Simeonidis, S.; Castagliuolo, I.; Pan, A.; Liu, J.; Wang, C.C.; Mykoniatis A, Pasha A, Valenick L, Sougioultzis S, Zhao D, Pothoulakis C. Proc. Natl. Acad. Sci. USA, 2003, 100, 2957.
49. Bandari PS, Qian J, Oh HS, Potian JA, Yehia G, Harrison JS, Rameshwar P. J. Neuroimmunol., 2003, 138, 65.
50. Bandari, P.S.; Qian, J.; Yehia, G.; Seegopaul, H.P.; Harrison, J.S.; Gascon, P.; Fernandes, H.; Rameshwar, P. Neuropeptides, 2002, 36, 13.
51. Almeida, P.F.F.; Pokorny, A.; Hinderliter, A. Biochim. Biophys. Acta, 2005, 1720, 1.
52. Garland, A.M.; Grady, E.F.; Lovett, M.; Vigna, S.R.; Frucht, M.M.; Krause, J.E.; Bunnett, N.W. Mol. Pharmacol., 1996, 49, 438.
53. van Rheenen, J.; Achame, E.M.; Calafat, J.; Jalink, K. EMBO J., 2005, 24, 1664.
54. Pike, L.J. J. Lipid Res., 2003, 44, 655.
55. Wysoczynski, M.; Reca, R.; Ratajczak, J.; Kucia, M.; Shirvaikar, N.; Honczarenko, M.; Mills, M.; Wanzeck, J.; Janowska-Wieczorek, A.; Ratajczak, M.Z. Blood, 2005, 105, 40.
56. Schabath, H.; Runz, S.; Joumaa, S.; Altevogt, P. J. Cell. Sci., 2006, 119, 314.
57. Sadir, R.; Imberty, A.; Baleux, F.; Lortat-Jacob, H. J. Biol. Chem., 2004, 279, 43854.
58. Monastyrskaya, K.; Hostettler, A.; Buergi, S.; Draeger, A. J. Biol. Chem., 2005, 280, 7135.
59. Cezanne, L.; Lecat, S.; Lagane, B.; Millot, C.; Vollmer, J.Y.; Matthes, H.; Galzi, J.L.; Lopez, A. J. Biol. Chem., 2004, 43, 45057.
60. Sarnataro, D.; Pisanti, S.; Santoro, A.; Gazzerro, P.; Malfitano, A.M.; Laezza, C.; Bifulco, M. Mol. Pharmacol., 2006, 70, 1298.
61. Braun, S.; Kentenich, C.; Janni, W.; Hepp, F.; de Waal, J.; Wilgeroth, F.; Sommer, H.; Klwus, P. J. Clin. Oncol., 2000, 18, 80.